Journal of the American Chemical Society · 2024 · 34 citations · 43 references
PharmacyMolecular BiologyPharmaceuticsDrug DeliveryGene DeliveryGenome EditingGene Delivery To The LungGene Delivery VectorsMessenger Rna DeliveryNucleic Acid DeliveryRna PolyadenylationRna TransportMessenger Rna ReleaseMrna DeliveryMrna Delivery SystemsMrna FormulationRna Delivery SystemsRna Delivery To The Lung
Selective RNA delivery is required for the broad implementation of RNA clinical applications, including prophylactic and therapeutic vaccinations, immunotherapies for cancer, and genome editing. Current polyanion delivery relies heavily on cationic amines, while cationic guanidinium systems have received limited attention due in part to their strong polyanion association, which impedes intracellular polyanion release. Here, we disclose a general solution to this problem in which cationic guanidinium groups are used to form stable RNA complexes upon formulation but at physiological pH undergo a novel charge-neutralization process, resulting in RNA release. This new delivery system consists of guanidinylated serinol moieties incorporated into a charge-altering releasable transporter (GSer-CARTs). Significantly, systematic variations in structure and formulation resulted in GSer-CARTs that exhibit highly selective mRNA delivery to the lung (∼97%) and spleen (∼98%) without targeting ligands. Illustrative of their breadth and translational potential, GSer-CARTs deliver circRNA, providing the basis for a cancer vaccination strategy, which in a murine model resulted in antigen-specific immune responses and effective suppression of established tumors.
43
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz, Mustafa Diken, Heinrich Haas et al. · Nature · 2016 · 1.7K citations
Life Sciences, Immunology, Oncology +17